92 related articles for article (PubMed ID: 6224971)
1. Pharmacological basis for clinical use of antiandrogens.
Neumann F
J Steroid Biochem; 1983 Jul; 19(1A):391-402. PubMed ID: 6224971
[TBL] [Abstract][Full Text] [Related]
2. Cyproterone acetate in the treatment of sexual disorders: pharmacological base and clinical experience.
Neumann F; Kalmus J
Exp Clin Endocrinol; 1991; 98(2):71-80. PubMed ID: 1838080
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of antiandrogens.
Neumann F; Töpert M
J Steroid Biochem; 1986 Nov; 25(5B):885-95. PubMed ID: 2949114
[TBL] [Abstract][Full Text] [Related]
4. Androgen antagonists in androgen target tissues.
Tindall DJ; Chang CH; Lobl TJ; Cunningham GR
Pharmacol Ther; 1984; 24(3):367-400. PubMed ID: 6205409
[TBL] [Abstract][Full Text] [Related]
5. [Modification of fertility of the male by antiandrogens].
Moltz L; Neumann F; Hammerstein J
Gynakologe; 1980 Mar; 13(1):18-32. PubMed ID: 6219927
[TBL] [Abstract][Full Text] [Related]
6. Sexual maturation in male mice treated with cyproterone acetate from birth to puberty.
Jean-Faucher C; Berger M; De Turckheim M; Veyssiere G; Jean C
J Endocrinol; 1984 Jul; 102(1):103-7. PubMed ID: 6234374
[TBL] [Abstract][Full Text] [Related]
7. [Clinical use of antiandrogens in the female].
Moltz L; Schwartz U; Hammerstein J
Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908
[TBL] [Abstract][Full Text] [Related]
8. Effects of endocrine disruptors on prosobranch snails (Mollusca: Gastropoda) in the laboratory. Part III: Cyproterone acetate and vinclozolin as antiandrogens.
Tillmann M; Schulte-Oehlmann U; Duft M; Markert B; Oehlmann J
Ecotoxicology; 2001 Dec; 10(6):373-88. PubMed ID: 11759570
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology and potential use of cyproterone acetate.
Neumann F
Horm Metab Res; 1977 Jan; 9(1):1-13. PubMed ID: 66176
[No Abstract] [Full Text] [Related]
10. Clinical applications of antiandrogens.
Namer M
J Steroid Biochem; 1988 Oct; 31(4B):719-29. PubMed ID: 2462132
[TBL] [Abstract][Full Text] [Related]
11. Advantages and disadvantages of pure antiandrogens and of antiandrogens of the cyproterone acetate-type in the treatment of prostatic cancer.
Habenicht UF; Schröder H; el Etreby MF; Neumann F
Prog Clin Biol Res; 1988; 260():63-75. PubMed ID: 2966407
[No Abstract] [Full Text] [Related]
12. Antiandrogens.
Neri RO
Adv Sex Horm Res; 1976; 2():233-62. PubMed ID: 65117
[TBL] [Abstract][Full Text] [Related]
13. [Anti-androgen therapy in the female].
Schindler AE
Geburtshilfe Frauenheilkd; 1990 Oct; 50(10):749-53. PubMed ID: 1704865
[TBL] [Abstract][Full Text] [Related]
14. [Antiandrogens].
Neumann F
Med Klin; 1973 Mar; 68(11):329-33. PubMed ID: 4266295
[No Abstract] [Full Text] [Related]
15. Use of cyproterone acetate in animal and clinical trials.
Neumann F
Gynecol Invest; 1971; 2(1):150-79. PubMed ID: 4949823
[No Abstract] [Full Text] [Related]
16. [Available anti-androgens for treating skin hyperandrogenism].
Pugeat M
Rev Fr Gynecol Obstet; 1989 Jun; 84(6):505-8. PubMed ID: 2528199
[TBL] [Abstract][Full Text] [Related]
17. [Cyproterone acetate in the treatment of girls with central precocious puberty].
Snajderová M; Lebl J; Zemková D; Zounarová M; Dvorák P; Kolousková S
Cesk Pediatr; 1991 Mar; 46(3):146-8. PubMed ID: 1832589
[TBL] [Abstract][Full Text] [Related]
18. Effect of antiandrogens on the accessory sex glands of castrated rats.
Umapathy E; Rai UC
Indian J Exp Biol; 1980 Oct; 18(10):1090-3. PubMed ID: 6452405
[No Abstract] [Full Text] [Related]
19. [Indications and limits of anti-androgen therapy].
Zaun H
Z Hautkr; 1984 Aug; 59(16):1090-7. PubMed ID: 6207673
[TBL] [Abstract][Full Text] [Related]
20. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
Paris F; Rabeolina F; Balaguer P; Bacquet A; Sultan C
Gynecol Endocrinol; 2007 Apr; 23(4):193-7. PubMed ID: 17505938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
